scholarly journals Training program in cancer and blood diseases: Pediatric Hematology/Oncology Fellowship Program, Children's Hospital Boston/Dana-Farber Cancer Institute

2010 ◽  
Vol 85 (10) ◽  
pp. 793-794
Author(s):  
David A. Williams ◽  
Elise S. Porter ◽  
Samuel E. Lux ◽  
Holcombe E. Grier ◽  
Jennifer W. Mack ◽  
...  
Keyword(s):  
Training Program ◽  
Fellowship Program ◽  
Blood Diseases ◽  
Children's Hospital ◽  
Pediatric Hematology ◽  
Dana Farber Cancer Institute ◽  
Children’S Hospital

Evaluation of anti-infectives prescriptions in a pediatric hemato-oncological center: A retrospective study

2018 ◽  
Vol 25 (8) ◽  
pp. 1811-1816
Author(s):  
Boubacar BF Diop ◽  
Amine Cheikh ◽  
Houda Attjioui ◽  
Mohamed R Ajaja ◽  
Hafid Mefetah ◽  
...  
Keyword(s):  
Information System ◽  
Drug Interaction ◽  
Retrospective Study ◽  
Drug Interactions ◽  
Training Program ◽  
Bacterial Resistance ◽  
Children's Hospital ◽  
Children’S Hospital ◽  
Oncological Center

Introduction A few years after the discovery and development of anti-infectives, this therapeutic feat gave way to bacterial resistance because of the overconsumption of antibiotics, most often with unjustified prescriptions. The objective was to evaluate the compliance of the prescription of antibiotherapy in the pediatric onco-hematology unit of Rabat Children's Hospital and to determine the drug interactions. Material and methods This is a retrospective study of anti-infectives prescriptions in pediatric onco-hematology. All prescriptions containing an antibiotic or antimycotic were isolated at the end of each month for analysis according to the ANSM standard. The variables of compliance analyzed in the prescriptions were: form, indication, posology, duration of the treatment, drug interactions and number of antibiotics which were prescribed. Results The prescriptions containing at least one anti-infective were 195. All the prescriptions were in conformity with their indications; 111 (57%) of the cases were conform with respect to all criteria; 20 (12%) prescriptions were not conform in their form, 12 (6.6%) contained at least one over-dosed drug and 52 (26.7%) contained at least one under-dosed drug. A drug interaction was found in 15 (7.7%) of cases, of which 12 (6.2%) are precautions for use. A drug interaction is present in 1(6,7%) cases when a single antibiotic is prescribed against 3 (20%) cases when 4 antibiotics are prescribed. ( p = 0.007). Conclusion The number of non-compliances in our study was high. It would therefore be advisable to recommend the establishment of an information system to minimize the non-compliances and to ensure a training program for young doctors on international recommendations.

Bloodstream Infections in Pediatric Oncology Outpatients: A New Healthcare Systems Challenge

2002 ◽  
Vol 23 (5) ◽  
pp. 239-243 ◽  
Author(s):  
Theresa L. Smith ◽  
Gregg T. Pullen ◽  
Vonda Crouse ◽  
Jon Rosenberg ◽  
William R. Jarvis
Keyword(s):  
Bloodstream Infections ◽  
Venous Catheter ◽  
Case Patient ◽  
Gram Negative ◽  
Children's Hospital ◽  
Pediatric Hematology ◽  
Patient Demographics ◽  
Children’S Hospital ◽  
And Control ◽  
Control Study

Objective:To investigate a perceived increase in central venous catheter (CVC)–associated bloodstream infections (BSIs) among pediatric hematology–oncology outpatients.Design:A case–control study.Setting:A pediatric hematology–oncology outpatient clinic at Fresno Children's Hospital.Patients:Pediatric hematology–oncology clinic outpatients with CVCs at Fresno Children's Hospital between November 1994 and October 1997.Methods:A case-patient was defined as any hematology–oncology outpatient with a CVC-associated BSI at Fresno Children's Hospital from November 1996 to October 1997 (study period) without a localizable infection. To identify case-patients, we reviewed Fresno Children's Hospital records for all hematology–oncology clinic patients, those with CVCs and those with CVCs and BSIs. Control-patients were randomly selected hematology–oncology outpatients with a CVC but no BSI during the study period. Case-patient and control-patient demographics, diagnoses, caretakers, catheter types, catheter care, and water exposure were compared.Results:Twenty-five case-patients had 42 CVC-associated BSIs during the study period. No significant increase in CVC-associated BSI rates occurred among pediatric hematology–oncology patients. However, there was a statistically significant increase in nonendogenous, gram-negative (eg, Pseudomonas species) BSIs during summer months (May–October) compared with the rest of the year. Case-patients and control-patients differed only in catheter type; case-patients were more likely than control-patients to have a transcutaneous CVC. Summertime recreational water exposures were similar and high in the two groups.Conclusions:Hematology–oncology clinic patients with transcutaneous CVCs are at greater risk for CVC-associated BSI, particularly during the summer. Caretakers should be instructed on proper care of CVCs, particularly protection of CVCs during bathing and recreational summer water activities, to reduce the risk of nonendogenous, gram-negative BSIs.

Inspire Certification Among Pediatric Hematology Oncology Nurses

2019 ◽  
Vol 36 (5) ◽  
pp. 337-342
Author(s):  
Diane Altounji ◽  
Sonya Williams ◽  
Rita Secola
Keyword(s):  
Los Angeles ◽  
Oncology Nurses ◽  
Independent Study ◽  
Staff Nurse ◽  
Long Term Effects ◽  
Children's Hospital ◽  
Pediatric Hematology ◽  
Oncology Nurse ◽  
Children’S Hospital ◽  
Review Course

Professional certification validates nurses’ knowledge and expertise in their specialty. In support of professional development, nursing excellence as a Magnet® designated hospital, and commitment to improve patient outcomes, increasing the number of certified pediatric hematology oncology nurses at Children’s Hospital Los Angeles is a priority. Expert certified nurses and educators assessed current staff nurse perceptions of and motivations for becoming certified. A nurse survey was completed, and the results identified barriers to certification and the need for an onsite review course to encourage more nurses to take the Certified Pediatric Hematology Oncology Nurse (CPHON®) exam. The Oncology Nursing Certification Corporation (ONCC) CPHON® test blueprint guided the development of the Children’s Hospital Los Angeles review course curriculum. Certified nurse experts volunteered as course instructors to present an overview of pediatric cancer, pediatric hematology, psychosocial review, chemotherapy and related medications, and long-term effects. In addition to course didactics, interactive learning sessions were included to allow participants to question, discuss, and apply new knowledge. Sample test questions were provided to each participant for independent study post–course attendance. Each participant completed course evaluations to measure the usefulness of the content, environment, and teaching methods. Since the implementation of this course, the overall number of certified hematology oncology nurses has increased by 15.3%.

Sign in / Sign up

Export Citation Format

Share Document